Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Endocytic trafficking and recycling maintain a pool of mobile surface AMPA receptors required for synaptic potentiation.

Petrini EM, Lu J, Cognet L, Lounis B, Ehlers MD, Choquet D.

Neuron. 2009 Jul 16;63(1):92-105. doi: 10.1016/j.neuron.2009.05.025.

2.

Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory.

Koob GF.

Pharmacopsychiatry. 2009 May;42 Suppl 1:S32-41. doi: 10.1055/s-0029-1216356. Epub 2009 May 11. Review.

3.

Extended daily access to cocaine results in distinct alterations in Homer 1b/c and NMDA receptor subunit expression within the medial prefrontal cortex.

Ben-Shahar O, Obara I, Ary AW, Ma N, Mangiardi MA, Medina RL, Szumlinski KK.

Synapse. 2009 Jul;63(7):598-609. doi: 10.1002/syn.20640.

4.

Glutamate receptors on dopamine neurons control the persistence of cocaine seeking.

Engblom D, Bilbao A, Sanchis-Segura C, Dahan L, Perreau-Lenz S, Balland B, Parkitna JR, Luján R, Halbout B, Mameli M, Parlato R, Sprengel R, Lüscher C, Schütz G, Spanagel R.

Neuron. 2008 Aug 14;59(3):497-508. doi: 10.1016/j.neuron.2008.07.010.

5.

Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving.

Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng LJ, Shaham Y, Marinelli M, Wolf ME.

Nature. 2008 Jul 3;454(7200):118-21. doi: 10.1038/nature06995. Epub 2008 May 25.

6.

CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking.

Anderson SM, Famous KR, Sadri-Vakili G, Kumaresan V, Schmidt HD, Bass CE, Terwilliger EF, Cha JH, Pierce RC.

Nat Neurosci. 2008 Mar;11(3):344-53. doi: 10.1038/nn2054. Epub 2008 Feb 17. Erratum in: Nat Neurosci. 2008 May;11(5):617.

PMID:
18278040
7.

Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD.

Xu W, Schlüter OM, Steiner P, Czervionke BL, Sabatini B, Malenka RC.

Neuron. 2008 Jan 24;57(2):248-62. doi: 10.1016/j.neuron.2007.11.027.

9.

Postsynaptic positioning of endocytic zones and AMPA receptor cycling by physical coupling of dynamin-3 to Homer.

Lu J, Helton TD, Blanpied TA, Rácz B, Newpher TM, Weinberg RJ, Ehlers MD.

Neuron. 2007 Sep 20;55(6):874-89.

10.

Homers regulate drug-induced neuroplasticity: implications for addiction.

Szumlinski KK, Ary AW, Lominac KD.

Biochem Pharmacol. 2008 Jan 1;75(1):112-33. Epub 2007 Jul 27. Review.

11.

NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders.

Lau CG, Zukin RS.

Nat Rev Neurosci. 2007 Jun;8(6):413-26. Review. Erratum in: Nat Rev Neurosci. 2007 Jul;8(7):568.

PMID:
17514195
12.

Effects of aging and caloric restriction on dentate gyrus synapses and glutamate receptor subunits.

Newton IG, Forbes ME, Linville MC, Pang H, Tucker EW, Riddle DR, Brunso-Bechtold JK.

Neurobiol Aging. 2008 Sep;29(9):1308-18. Epub 2007 Apr 11.

13.

The postsynaptic density.

Boeckers TM.

Cell Tissue Res. 2006 Nov;326(2):409-22. Epub 2006 Jul 25. Review.

PMID:
16865346
14.

Homer proteins: implications for neuropsychiatric disorders.

Szumlinski KK, Kalivas PW, Worley PF.

Curr Opin Neurobiol. 2006 Jun;16(3):251-7. Epub 2006 May 15. Review.

PMID:
16704932
15.

Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers.

Drakenberg K, Nikoshkov A, Horváth MC, Fagergren P, Gharibyan A, Saarelainen K, Rahman S, Nylander I, Bakalkin G, Rajs J, Keller E, Hurd YL.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7883-8. Epub 2006 May 8.

16.

Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression.

Bellone C, Lüscher C.

Nat Neurosci. 2006 May;9(5):636-41. Epub 2006 Apr 2.

PMID:
16582902
17.
18.

Synaptic expression of glutamate receptor after encoding of fear memory in the rat amygdala.

Yeh SH, Mao SC, Lin HC, Gean PW.

Mol Pharmacol. 2006 Jan;69(1):299-308. Epub 2005 Oct 11.

20.

Homer isoforms differentially regulate cocaine-induced neuroplasticity.

Szumlinski KK, Abernathy KE, Oleson EB, Klugmann M, Lominac KD, He DY, Ron D, During M, Kalivas PW.

Neuropsychopharmacology. 2006 Apr;31(4):768-77.

Supplemental Content

Support Center